Dr. Viswanathan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave NW
Ste 100
Washington, DC 20010Phone+1 202-476-6151Fax+1 202-476-3850
Education & Training
Children's National Hospital/George Washington UniversityFellowship, Pediatric Infectious Diseases, 2010 - 2013
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2003 - 2006
University of Kansas School of MedicineClass of 2003
Certifications & Licensure
DC State Medical License 2010 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- 28 citationsCobicistat-containing antiretroviral regimens are not recommended during pregnancy: viewpoint.Sarita D. Boyd, Mario R Sampson, Prabha Viswanathan, Kimberly A Struble, Vikram Arya
AIDS. 2019-05-01 - 6 citationsUS FDA Perspective on Elbasvir/Grazoprevir Treatment for Patients with Chronic Hepatitis C Virus Genotype 1 or 4 Infection.Sarita D. Boyd, LaRee Tracy, Takashi E. Komatsu, Patrick R. Harrington, Prabha Viswanathan
Clinical Drug Investigation. 2017-01-19 - 14 citationsHypoglycemia in Patients Treated With LinezolidPrabha Viswanathan, Dmitri Iarikov, Ronald T. Wassel, Alma Davidson, Sumathi Nambiar
Clinical Infectious Diseases. 2014-10-15
Journal Articles
- Effects of Sorbitol on the Pharmacokinetics of Lamivudine Solution and the FDA's Decision to Increase the Dose of Lamivudine Solution for Pediatric PatientsPrabha Viswanathan, MD, Clinical Pharmacology & Therapeutics
Press Mentions
- Schools Should Normalize Pauses for Coronavirus SafetyJanuary 25th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
